Borderline tumours of ovary and fertility preservation-Outcomes from a tertiary care center in India.

Borderline ovarian tumour Fertility sparing surgery Pregnancy Radical surgery Recurrence Survival

Journal

Current problems in cancer
ISSN: 1535-6345
Titre abrégé: Curr Probl Cancer
Pays: United States
ID NLM: 7702986

Informations de publication

Date de publication:
09 Apr 2024
Historique:
received: 09 12 2023
revised: 18 03 2024
accepted: 03 04 2024
medline: 11 4 2024
pubmed: 11 4 2024
entrez: 10 4 2024
Statut: aheadofprint

Résumé

Borderline ovarian tumors (BOT) are characterized by atypical epithelial proliferation without stromal invasion and majority are diagnosed in women of reproductive age group desirous of fertility preservation. A retrospective review of medical records of patients diagnosed with BOT and on regular follow up at the All India Institute of Medical Sciences New Delhi, during a nine-year study period from March 2014 to March 2023 was performed. Surgical treatment was classified as radical or fertility sparing surgery (FSS). Surgical staging was defined as complete, partial or un-staged. Median age of 91 women was 34 years. Follow up period ranged from 4 to 222 months (median 77 months). Among 68 premenopausal women, 31 (46 %) underwent radical surgery and FSS in 37 (54 %) cases. Median time to conception in 29 women with future fertility wishes was 13 months (range, 4 to38 m). Seven of 29 cases (29 %) required ovulation induction. The pregnancy rate was 82.7 % and live birth rate was 80 %. Eight cases (8.7 %) had a recurrence (7- un-staged, 1- partially staged) and median time to recur was 36 months. There was no significant difference in recurrence between cystectomy/oophorectomy. Ovary was the site of recurrence in all surgically salvaged cases except peritoneal cavity in 1 case with mortality. Relapse free survival at 5 and 10 years in FSS and radical surgery group were similar. FSS is a safe procedure and should be considered in young patients desirous of future fertility along with a comprehensive peritoneal staging. Reproductive outcomes are excellent.

Identifiants

pubmed: 38598972
pii: S0147-0272(24)00038-2
doi: 10.1016/j.currproblcancer.2024.101097
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101097

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sarita Kumari (S)

Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.

Neerja Bhatla (N)

Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.

Chandrima Ray (C)

Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.

Bhawna Arora (B)

Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.

Sandeep Mathur (S)

Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Sunesh Kumar (S)

Department of Gynaecology, Sitaram Bhartia Institute of Science and Research, New Delhi, India.

Lalit Kumar (L)

Department of Medical Oncology, Artemis Hospitals, Gurugram, India. Electronic address: lalitaiims@yahoo.com.

Classifications MeSH